Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Solexa Raises $65M, Readies Sequencing System Launch

Nov. 22, 2005

By Jennifer Boggs

Solexa Raises $65M, Readies Sequencing System Launch

Nov. 22, 2005

By Jennifer Boggs

Gilead Reports Positive Truvada Data; FDA Probes Tamiflu Deaths

Nov. 21, 2005

By Jennifer Boggs

Vernalis Buying Cita, Picking Up Third Parkinson's Product

Nov. 21, 2005

By Jennifer Boggs

American BioScience Licenses Japanese Rights To Abraxane

Nov. 17, 2005

By Jennifer Boggs

American BioScience Licenses Japanese Rights To Abraxane

Nov. 17, 2005

By Jennifer Boggs

Gilead: Five-Year Hepsera Data Show Continued Efficacy In HBV

Nov. 16, 2005

By Jennifer Boggs

Gilead: Five-Year Hepsera Data Show Continued Efficacy In HBV

Nov. 16, 2005

By Jennifer Boggs

Speedel Presents Confirmatory Positive SPP301 Phase II Data

Nov. 15, 2005

By Jennifer Boggs

Speedel Presents Confirmatory Positive SPP301 Phase II Data

Nov. 15, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...